Feb 19 (Reuters) - Adial Pharmaceuticals Inc ADIL.O:
ADIAL PHARMACEUTICALS GRANTED NEW U.S. PATENT EXPANDING COVERAGE OF ITS GENETIC-BASED APPROACH TO TREATING AND DIAGNOSING ALCOHOL USE DISORDER AND OTHER DRUG DEPENDENCIES
Source text: nGNX41V4YB
Further company coverage: ADIL.O